Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

General Surgical Innovations

This article was originally published in The Gray Sheet

Executive Summary

Manufacturer of tissue dissection systems for minimally invasive surgery reports Aug. 4 that it will be allowed to recover legal fees in connection with a patent infringement suit filed by Guidant subsidiary Origin Medsystems in San Jose, California federal court. Earlier, the court found that Origin had obtained the patent through misrepresentations, according to GSI. For the fourth quarter ended June 30, GSI reported revenues of $1.3 mil., down from $2.5 mil. in the fourth quarter of fiscal 1997, and a net loss of $3 mil. versus $971,000 a year ago. For the 12 months, revenues advanced 24% to $5.2 mil., and the company's net loss increased to $9.1 mil. from $1.9 mil. in 1997

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010461

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel